Form 4: Cencora Inc. CEO Steven Collis Executes Stock Option and Sells Shares Under 10b5-1 Plan

Cencora's CEO, Steven H. Collis, exercised stock options and sold shares of common stock on August 20, 2024, according to a Form 4 filing with the SEC.

Summary

• On August 20, 2024, Steven H. Collis, the Chairman, President, and CEO of Cencora, Inc., exercised non-qualified stock options to acquire 10,754 shares of common stock at a price of $89.58 per share.
• Simultaneously, Collis sold 10,754 shares of Cencora common stock at a price of $239.13 per share.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on December 18, 2023, and disclosed in a previous 8-K filing.
• Following these transactions, Collis directly owns 285,088 shares of Cencora common stock.
• He also holds options to purchase 64,527 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

Executive stock transactions are common and closely monitored, especially in publicly traded companies like Cencora. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of trading on non-public information.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to manage their stock holdings in a compliant manner.
• Comparable companies such as McKesson and Cardinal Health also have executives who utilize similar trading plans.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates concerns about insider information.

Key Dates